ATOPIC 25mg FOR DOGS Dermatological, anti-inflammatory and non-steroidal antipruritic in soft capsules Laboratory: NOVARTIS ANIMAL HEALTH SL Contraindications: • Do not use in cases of hypersensitivity to cyclosporine or to any of the excipients. • For any concentration of the capsules, do not use in dogs less than six months of age or less than 2 kg in weight. • Do not use in animals with a clinical history of malignant tumors. • Do not vaccinate with a live vaccine during treatment or during the two weeks before or after treatment. (See also the points “Special precautions” and “Interactions and incompatibilities”). Route of administration:: Oral. Atopica® should be given at least 2 hours before or after meals. Insert the capsule directly into the dog's mouth. Posology: Dogs: The average recommended dose of cyclosporine is 5 mg/kg of body weight according to the following schedule: Dog weight* Number of capsules administered to achieve the recommended dose 4 to <7,5 kg 1 Atopica® 25 mg capsule 7,5 to <15 kg 1 Atopica® 50 mg capsule 15 to <29 kg 1 Atopica® 100 mg capsule 29 to <36 kg 1 Atopica® 100 mg capsule 1 Atopica® 50 mg capsule 36 to <55 kg 2 Atopica® 100 mg capsules * For higher weights, proceed according to the average recommended dose. • Initially Atopica® will be administered daily until satisfactory clinical improvement is seen. This usually happens within 4 weeks. If there is no improvement during the first 8 weeks, treatment should be stopped. • Once the clinical symptoms of atopic dermatitis have been satisfactorily controlled, the product can be given every other day as a maintenance dose. The veterinarian must make clinical controls at regular intervals and adjust the frequency of administration to the clinical response obtained. • In cases where symptoms are controlled with alternate day administration, the veterinarian may decide to give Atopica® every 3 to 4 days. • Before reducing the treatment interval, consideration should be given to giving additional treatment (eg medicated shampoos, fatty acids). • Treatment can be stopped when clinical symptoms have been controlled. If clinical symptoms reappear, treatment can be resumed at a daily dose, in some cases several courses of treatment will be necessary. Wait time:: Not applicable. Conservation mode:: Do not store above 25 °C. Store in the blister. Keep the blister in the outer carton packaging.